-
公开(公告)号：US20120225103A1
公开(公告)日：2012-09-06
申请号：US13473724
申请日：2012-05-17
申请人： Frank THEOBALD , Wolfgang LAUX , Beatrix PLATT , Regine KAUFMANN
发明人： Frank THEOBALD , Wolfgang LAUX , Beatrix PLATT , Regine KAUFMANN
IPC分类号： A61K9/70 , A61M35/00 , A61K31/428
CPC分类号： A61K9/7061 , A61K31/428
摘要： This invention relates to a transdermal therapeutic system (TTS) releasing an active pramipexol agent during a time ranging from 4 to 7 days.
摘要翻译： 本发明涉及一种在4至7天的时间内释放活性的普拉克索剂的透皮治疗系统（TTS）。
-
公开(公告)号：US20110313372A1
公开(公告)日：2011-12-22
申请号：US13162604
申请日：2011-06-17
申请人： René EIFLER , Michael Horstmann , Regine Kaufmann , Patrick Mohr
发明人： René EIFLER , Michael Horstmann , Regine Kaufmann , Patrick Mohr
IPC分类号： A61M35/00 , A61K31/13 , A61P25/00 , A61P25/30 , A61P25/16 , A61P25/24 , A61P25/08 , A61K9/70 , A61P25/28
CPC分类号： A61K9/7053 , A61K9/7061 , A61K31/13
摘要： The invention relates to transdermal therapeutic systems (TTS) which include, as active ingredient, the NMDA receptor antagonist memantine or one of its physiologically compatible salts. The TTSs can be produced and used for treating diseases of the central nervous system.
摘要翻译： 本发明涉及透皮治疗系统（TTS），其包括作为活性成分的NMDA受体拮抗剂美金刚或其生理上相容的盐之一。 TTS可用于治疗中枢神经系统疾病。
-
公开(公告)号：US09833418B2
公开(公告)日：2017-12-05
申请号：US13321586
申请日：2010-05-19
申请人： René Eifler , Regine Kaufmann , Patrick Mohr
发明人： René Eifler , Regine Kaufmann , Patrick Mohr
CPC分类号： A61K9/7061 , A61K31/13 , A61K47/02 , Y10T156/10
摘要： The present invention relates to transdermal therapeutic systems that include an occlusive back layer impervious to an active substance, a single or multilayer matrix, and a peelable protective film. The matrix or at least one of the matrix layers includes a pharmaceutical active substance or a plurality of pharmaceutical active substances in the form of at least one pharmaceutically consumable salt thereof and a pharmaceutically consumable, alkaline reacting oxide.
-
公开(公告)号：US20060182791A1
公开(公告)日：2006-08-17
申请号：US10564932
申请日：2004-07-14
申请人： Frank Theobald , Wolfgang Laux , Beatrix Platt , Regine Kaufmann
发明人： Frank Theobald , Wolfgang Laux , Beatrix Platt , Regine Kaufmann
IPC分类号： A61K31/428 , A61K9/70
CPC分类号： A61K9/7061 , A61K31/428
摘要： The invention relates to a transdermal therapeutic system (TTS) releasing an active pramipexol agent during a time ranging from 4 to 7 hours.
摘要翻译： 本发明涉及在4至7小时的时间内释放活性的普立立姆剂的透皮治疗系统（TTS）。
-
公开(公告)号：US10363228B2
公开(公告)日：2019-07-30
申请号：US13162604
申请日：2011-06-17
申请人： René Eifler , Michael Horstmann , Regine Kaufmann , Patrick Mohr , Eric Galia , Wolfgang Prange , Stefan Buller , Klaus Pusecker , Jan Stampfuss , Susanne Stoelben
发明人： René Eifler , Michael Horstmann , Regine Kaufmann , Patrick Mohr , Eric Galia , Wolfgang Prange , Stefan Buller , Klaus Pusecker , Jan Stampfuss , Susanne Stoelben
摘要： The invention relates to transdermal therapeutic systems (TTS) which include, as active ingredient, the NMDA receptor antagonist memantine or one of its physiologically compatible salts. The TTSs can be produced and used for treating diseases of the central nervous system.
-
6.发明申请Transdermal Therapeutic System Having Controlled Active Substance Flow Comprising a Basic Reacting Oxide 有权控制包含基本反应氧化物的活性物质流的透皮治疗系统公开(公告)号：US20120065599A1
公开(公告)日：2012-03-15
申请号：US13321586
申请日：2010-05-19
申请人： René Eifler , Regine Kaufmann , Patrick Mohr
发明人： René Eifler , Regine Kaufmann , Patrick Mohr
CPC分类号： A61K9/7061 , A61K31/13 , A61K47/02 , Y10T156/10
摘要： The present invention relates to transdermal therapeutic systems that include an occlusive back layer impervious to an active substance, a single or multilayer matrix, and a peelable protective film. The matrix or at least one of the matrix layers includes a pharmaceutical active substance or a plurality of pharmaceutical active substances in the form of at least one pharmaceutically consumable salt thereof and a pharmaceutically consumable, alkaline reacting oxide.
摘要翻译： 本发明涉及透皮治疗系统，其包括不透过活性物质的闭塞性背层，单层或多层基质和可剥离保护膜。 基质或至少一种基质层包括药物活性物质或其至少一种药学上可食用的盐和药学上可消耗的碱性反应氧化物形式的多种药物活性物质。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.025 秒)